Search Blog
Categories
June 2018
M T W T F S S
« May   Jul »
 123
45678910
11121314151617
18192021222324
252627282930  

Tags

MBVX: Pawar Reminds of Important Lead Plaintiff Deadline in MabVax Therapeutics Holdings, Inc. Class Action – MBVX

ACCESSWIRE

By Pawar Law Group

NEW YORK, NY / ACCESSWIRE / June 15, 2018 / Pawar Law Group announces that a class action lawsuit has been filed on behalf of shareholders who purchased shares of MabVax Therapeutics Holdings, Inc. (NASDAQ: MBVX) between March 14, 2016 and May 18, 2018, both dates inclusive (the “Class Period”). The lawsuit seeks to recover damages for MabVax investors under the federal securities laws. To join the MabVax class action, go to http://pawarlawgroup.com/cases/mabvax-therapeutics-holdings-inc/ or call Vik Pawar, Esq. toll-free at 888-589-9804 or email vik@pawarlawgroup.com for information on the class action.

No class has yet been certified in the above action. Until a class is certified, you are not represented by counsel unless you retain one. You may also remain an absent class member and do nothing at this point. You may retain counsel of your choice.

According to the lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) MabVax’s internal controls over financial reporting were materially weak and deficient; (2) MabVax had incorrectly calculated and reported beneficial ownership of MabVax shares, and permitted improper influence or control over MabVax, and/or MabVax’s officers and directors by certain shareholders; and (3) as a result, MabVax’s financial statements and defendants’ statements about MabVax’s business, operations, and prospects were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than August 3, 2018. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. If you wish to join the litigation, go to http://pawarlawgroup.com/cases/mabvax-therapeutics-holdings-inc/ to join the class action. You may also contact Vik Pawar of Rosen Law Firm toll free at 888-589-9804 or via email at vik@pawarlawgroup.com.

Pawar Law Group represents investors from around the world.

Attorney Advertising. Prior results do not guarantee a similar outcome.


Contact:

Vik Pawar, Esq.
Pawar Law Group
20 Vesey Street, Suite 1210
New York, NY 10007
Tel: (917) 261-2277
Fax: (212) 571-0938
info@pawarlawgroup.com

SOURCE: Pawar Law Group

ReleaseID: 502855